Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 21 (9) , 1926-1927
Abstract
Here, we report two cases of severe rhabdomyolysis, regarding patients with metastatic renal cell cancer (RCC) receiving treatment with sunitinib.Keywords
This publication has 5 references indexed in Scilit:
- Rhabdomyolysis Resulting from Pharmacologic Interaction Between Erlotinib and SimvastatinClinical Lung Cancer, 2008
- Imatinib as a Possible Cause of Severe RhabdomyolysisNew England Journal of Medicine, 2008
- Bortezomib-Induced Rhabdomyolysis in Multiple MyelomaActa Haematologica, 2006
- Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanomaThe Lancet, 1997
- Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaCancer, 1995